Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Post-Neurotomy Neuritis Prevention After Radiofrequency Neurotomy
NCT07839195Phase 2Enrolling by invitation
- Sponsor
- Siriraj Hospital
- Start
- Oct 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone in post-neurotomy neuritis (PNN) (2 arms), sponsored by Siriraj Hospital. Primary endpoint: Incidence of Post-Neurotomy Neuritis at 4 weeks. Started Oct 2026; status: enrolling by invitation.
02
Drugs
dexamethasone
03
Conditions
post-neurotomy neuritis (PNN)
Beyond the preview
Go deeper on NCT07839195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839195.